Essential functions of the Williams-Beuren syndrome-associated TFII-I genes in embryonic development
暂无分享,去创建一个
Ananda L Roy | F. Ruddle | N. Chimge | A. Makeyev | A. Roy | D. Bayarsaihan | Aleksandr V Makeyev | Frank H Ruddle | B. Enkhmandakh | L. Erdenechimeg | Nyam-Osor Chimge | Badam Enkhmandakh | Lkhamsuren Erdenechimeg | Maria Isabel Tussie-Luna | Dashzeveg Bayarsaihan | M. Tussié-Luna
[1] P. Fletcher,et al. Reduced fear and aggression and altered serotonin metabolism in Gtf2ird1‐targeted mice , 2008, Genes, brain, and behavior.
[2] A. Roy. Signal-induced functions of the transcription factor TFII-I. , 2007, Biochimica et biophysica acta.
[3] F. Ruddle,et al. Expression profiling of BEN regulated genes in mouse embryonic fibroblasts. , 2007, Journal of experimental zoology. Part B, Molecular and developmental evolution.
[4] F. Ruddle,et al. Gene expression analysis of TFII-I modulated genes in mouse embryonic fibroblasts. , 2007, Journal of experimental zoology. Part B, Molecular and developmental evolution.
[5] A. Roy,et al. Cutting Edge: TFII-I Controls B Cell Proliferation via Regulating NF-κB1 , 2007, The Journal of Immunology.
[6] Stephen J. Palmer,et al. Expression of Gtf2ird1, the Williams syndrome-associated gene, during mouse development. , 2007, Gene expression patterns : GEP.
[7] P. Sharp,et al. Opposing functions of TFII-I spliced isoforms in growth factor-induced gene expression. , 2006, Molecular cell.
[8] S. Snyder,et al. Action of TFII-I Outside the Nucleus as an Inhibitor of Agonist-Induced Calcium Entry , 2006, Science.
[9] M. Quigley,et al. Thoracolumbar Syrinx in Association With Williams Syndrome , 2006, Pediatrics.
[10] Joan Murphy,et al. Comparison of Respiratory Physiologic Features When Infants Are Placed in Car Safety Seats or Car Beds , 2006, Pediatrics.
[11] Joaquín Dopazo,et al. BABELOMICS: a systems biology perspective in the functional annotation of genome-scale experiments , 2006, Nucleic Acids Res..
[12] Robert H. Shoemaker,et al. Complex interactions of HIV-1 nucleocapsid protein with oligonucleotides , 2006, Nucleic Acids Research.
[13] Peter Hammond,et al. GTF2IRD1 in Craniofacial Development of Humans and Mice , 2005, Science.
[14] A. Buonanno,et al. Multiple GTF2I-like Repeats of General Transcription Factor 3 Exhibit DNA Binding Properties , 2005, Journal of Biological Chemistry.
[15] S. Desiderio,et al. Vascular Endothelial Growth Factor Receptor-2 , 2005, Journal of Biological Chemistry.
[16] May Tassabehji,et al. Comparison of TFII‐I gene family members deleted in Williams‐Beuren syndrome , 2004, Protein science : a publication of the Protein Society.
[17] F. Ruddle,et al. GTF2IRD2 is located in the Williams-Beuren syndrome critical region 7q11.23 and encodes a protein with two TFII-I-like helix-loop-helix repeats. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[18] F. Ruddle,et al. Expression of BEN, a member of TFII-I family of transcription factors, during mouse pre- and postimplantation development. , 2003, Gene expression patterns : GEP.
[19] A. Buonanno,et al. Characterization of General Transcription Factor 3, a Transcription Factor Involved in Slow Muscle-specific Gene Expression* , 2003, The Journal of Biological Chemistry.
[20] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[21] M. Goumans,et al. Abnormal angiogenesis but intact hematopoietic potential in TGF‐β type I receptor‐deficient mice , 2001, The EMBO journal.
[22] J. Ihle. The Challenges of Translating Knockout Phenotypes into Gene Function , 2000, Cell.
[23] F. Ruddle,et al. Isolation and characterization of BEN, a member of the TFII-I family of DNA-binding proteins containing distinct helix-loop-helix domains. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[24] M. Goumans,et al. Functional analysis of the TGFbeta receptor/Smad pathway through gene ablation in mice. , 2000, The International journal of developmental biology.
[25] P. Donahoe,et al. Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[26] P. Carmeliet,et al. Transgenic mouse models in angiogenesis and cardiovascular disease , 2000, The Journal of pathology.
[27] M. Goumans,et al. Transforming growth factor-beta signalling in extraembryonic mesoderm is required for yolk sac vasculogenesis in mice. , 1999, Development.
[28] Ursula Bellugi,et al. Bridging cognition, the brain and molecular genetics: evidence from Williams syndrome , 1999, Trends in Neurosciences.
[29] C. Deng,et al. Angiogenesis defects and mesenchymal apoptosis in mice lacking SMAD5. , 1999, Development.
[30] C. Patterson,et al. The Human KDR/flk-1 Gene Contains a Functional Initiator Element That Is Bound and Transactivated by TFII-I* , 1999, The Journal of Biological Chemistry.
[31] M. Taketo,et al. TGF-beta receptor type II deficiency results in defects of yolk sac hematopoiesis and vasculogenesis. , 1996, Developmental biology.
[32] Janet Rossant,et al. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice , 1995, Nature.
[33] H. King,et al. Kyphoscoliosis in Williams syndrome. , 1994, Spine.
[34] A. Roy,et al. Cutting Edge: TFII-I controls B cell proliferation via regulating NF-kappaB. , 2007, Journal of immunology.
[35] F. Ruddle,et al. The early embryonic expression of TFII-I during mouse preimplantation development. , 2004, Gene expression patterns : GEP.
[36] F. Ruddle,et al. Genomic organization of the genes Gtf2ird1, Gtf2i, and Ncf1 at the mouse chromosome 5 region syntenic to the human chromosome 7q11.23 Williams syndrome critical region. , 2002, Genomics.
[37] C A Morris,et al. Williams syndrome and related disorders. , 2000, Annual review of genomics and human genetics.